Shares of LTIMindtree gained mildly to Rs 6,262 apiece on November 27 after the company’s management revealed an ambitious target of reaching $10 billion in revenue by the fiscal year 2031-32 during ...

The brokerage suggested a ‘BUY’ for LTIMindtree with a target price of Rs 7,550. The LTIMindtree management expects to ...

We recently published a list of 15 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at ...

LTIMindtree rose 1.58% to Rs 6,212.35 after the company announced partnership with Microsoft to create go-to market strategy, make joint investments in AI-powered solutions. Their collaboration ...

LTIMindtree and Microsoft have formed a strategic alliance to accelerate Al-driven digital transformation for global ...

LTIMindtree and Microsoft partner to accelerate AI-driven digital transformation for global enterprises, focusing on secure, innovative solutions.

The Nifty IT index hit a record high on Tuesday, rising 1.4% to 44,240, with all 10 constituents in the positive. Infosys led ...

Shares of LTIMindtree Ltd. 1.14 per cent to Rs 6185.35 in Tuesday's session as of 10:24AM (IST) even as the equity benchmark ...

We attended LTIM’s Investor Day 2024, where the management spelt out its aspiration of achieving a revenue of USD10b and EBIT margin of 17-18% (the when and how of it were slightly vague, however).

LTIMindtree and Microsoft are joining forces to usher in a new era of Artificial Intelligence (AI) driven transformation.

Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced the successful closing of a $20.4 million round of financing ...